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Abbreviations 21 
mTOR – Mechanistic target of rapamycin  22 
LAMP2 – Lysosomal associated membrane protein 2 23 
WGA – Wheat Germ Agglutinin  24 
Raptor – Regulatory associated protein of mTOR 25 
Rictor – Rapamycin insensitive companion of mTOR 26 
GβL - G protein beta subunit-like  27 
PRAS40 - Proline-rich AKT1 substrate 1 of 40kDa 28 
DEPTOR - DEP domain-containing mTOR-interacting protein 29 
mSIN1 - Mammalian stress-activated protein kinase interacting protein 1 30 
Protor – Protein observed with Rictor 31 
MPS – Muscle protein synthesis 32 
MPB – Muscle protein breakdown 33 
S6K1 – Ribosomal protein S6 Kinase 1 34 
AKT - RAC serine/threonine-protein kinase/ Protein kinase B 35 
CASA – Chaperone assisted selective autophagy 36 
Rheb – Ras homolog enriched in brain 37 
eIF3F - Eukaryotic translation initiation factor 3 subunit F  38 
Abstract 39 
Mechanistic target of rapamycin (mTOR) resides as two complexes within skeletal muscle. 40 
mTOR complex 1 (mTORC1–Raptor positive) regulates skeletal muscle growth, whereas 41 
mTORC2 (Rictor positive) regulates insulin sensitivity. To examine the regulation of these 42 
complexes in human skeletal muscle, we utilised immunohistochemical analysis to study the 43 
localisation of mTOR complexes prior to and following protein-carbohydrate feeding (FED) 44 
and resistance exercise plus protein-carbohydrate feeding (EXFED) in a unilateral exercise 45 
model. In basal samples, mTOR and the lysosomal marker LAMP2 were highly co-localized 46 
and remained so throughout. In the FED and EXFED states, mTOR/LAMP2 complexes were 47 
redistributed to the cell periphery (WGA positive staining) (time effect; p=.025), with 39% 48 
(FED) and 26% (EXFED) increases in mTOR/WGA association observed 1h post-49 
feeding/exercise. mTOR/WGA colocalisation continued to increase in EXFED at 3h (48% 50 
above baseline) whereas colocalisation decreased in FED (21% above baseline).  A 51 
significant effect of condition (p=.05) was noted suggesting mTOR/WGA co-localization was 52 
greater during EXFED. This pattern was replicated in Raptor/WGA association, where a 53 
significant difference between EXFED and FED was noted at 3h post-exercise/feeding 54 
(p=.014). Rictor/WGA colocalization remained unaltered throughout the trial. Alterations in 55 
mTORC1 cellular location coincided with elevated S6K1 kinase activity, which rose to a 56 
greater extent in EXFED compared to FED at 1h post-exercise/feeding (p<.001), and only 57 
remained elevated in EXFED at the 3h time point (p=.037). Collectively these data suggest 58 
that mTORC1 redistribution within the cell is a fundamental response to resistance exercise 59 
and feeding, whereas mTORC2 is predominantly situated at the sarcolemma and does not 60 
alter localisation.  61 
 62 
Introduction 63 
Resistance exercise and protein ingestion are potent anabolic stimuli, elevating muscle 64 
protein synthesis (MPS) (5, 20) resulting in a positive net protein balance (NPB) (5). Such 65 
elevations in MPS are underpinned by the activation of the conserved serine/threonine kinase, 66 
mechanistic target of rapamycin (mTOR). This kinase can both augment MPS (17) and offset 67 
muscle protein breakdown (MPB) (19). In skeletal muscle, mTOR resides in two distinct 68 
complexes distinguishable by the composition of proteins within each. For example, complex 69 
1 (mTORC1) contains mTOR, RAPTOR, GβL, PRAS40 and DEPTOR (4), believed to 70 
activate protein synthetic machinery (1), whereas complex 2 (mTORC2) is comprised of 71 
mTOR, RICTOR, DEPTOR, GβL, Sin1 and Protor, and is implicated in insulin sensitivity 72 
and actin cytoskeleton dynamics (4). Due to the critical role mTORC1 plays in regulating 73 
protein synthesis, this complex has received the most detailed examination in relation to 74 
resistance exercise and protein feeding. Acute resistance exercise, protein ingestion, or 75 
combinations of such stimuli are consistently reported to elevate mTORC1 activity (5, 20), 76 
with effects maintained for up to 24 hours (6). Furthermore, the acute inhibition of mTORC1 77 
with rapamycin administration ablates any effect of anabolic stimuli on MPS (8, 9). 78 
As mTORC1 activity seems to be directly implicated in the stimulation of MPS, research has 79 
focussed on understanding the mechanism by which mTORC1 is activated. Sancak et al.(21), 80 
identified the interaction of mTORC1 with the lysosome to be of particular importance to the 81 
activation of the kinase complex in vitro. A similar mechanism has also been reported in 82 
rodent skeletal muscle, where eccentric contractions of the tibialis anterior muscle induce 83 
mTOR-lysosome colocalisation (13) in parallel to increases in mTORC1 activity (inferred by 84 
the phosphorylation of S6K1Thr389). Together these data infer an importance of mTOR-85 
lysosome colocalisation in the activation of molecular pathways implicated in protein 86 
synthesis. Recently, however, Korolchuk et al. (15) reported that the cellular localisation of 87 
these mTOR/lysosomal complexes play a pivotal role in mTOR activation. In support of this 88 
hypothesis, we recently reported that a single bout of resistance exercise initiated 89 
mTOR/lysosome translocation to the cell periphery, and occurred in parallel to an increase in 90 
mTOR activity and interaction between mTOR and proteins involved in translation initiation 91 
(23).  92 
Whilst the use of immunofluorescence approaches allowed us to study the cellular 93 
localisation of mTOR, this approach did not enable us to distinguish between mTOR 94 
complexes. Consequently, we were unable to conclude whether the movement of mTOR 95 
following anabolic stimuli was mTORC1 or mTORC2 specific. Further, given the parallel 96 
group design we employed (23), we were unable to assess whether mTOR translocation was 97 
amplified by feeding. Therefore, the aim of the current study was to evaluate whether mTOR 98 
translocation following resistance exercise and/or protein-carbohydrate feeding is specific to 99 
mTORC1. In addition, we utilised a within-subject design to evaluate whether a synergistic 100 
effect of exercise and feeding exists. We hypothesised that exercise plus protein-carbohydrate 101 
feeding would elicit a greater mTOR/LAMP2 translocation to the cell periphery compared to 102 
feeding alone. Further, we hypothesised this translocation would be specific to mTORC1. 103 
Methods 104 
Subjects. Eight young, healthy, recreationally active males (age=22.5±3.1y, 105 
BMI=24.6±2.2kg/m2, body fat=17.6±4.8%) volunteered to partake in the study. Potential 106 
participants were informed about all experimental procedures to be undertaken and any risks 107 
involved before written informed consent was obtained. The study was approved by the 108 
Hamilton Integrated Research Ethics Board (REB 14-736) and adhered to the ethical 109 
standards outlined by the Canadian tri-council policy statement regarding the use of human 110 
participants in research as well as the principles according to the Declaration of Helsinki as 111 
revised in 2008. 112 
Experimental design. Following initial assessment for 1 repetition maximum (1-RM) on leg 113 
extension 7 d previously, participants reported to the laboratory at ~7.00am after a 10-h 114 
overnight fast. Participants then rested in a semi-supine position on a bed and an initial 115 
skeletal muscle biopsy was taken from the vastus lateralis using a modified bergstrom 116 
needle. Following this biopsy, participants performed 4 sets of unilateral leg extension 117 
(Atlantis, Laval, QC, Canada) at 70% 1RM until volitional failure interspersed by 2 min 118 
recovery. Immediately following the cessation of the final set of leg extension all participants 119 
consumed a commercially available beverage (Gatorade Recover®, Chicago, IL, USA) that 120 
provided 20, 44, and 1g of protein, carbohydrate, and fat respectively. Subsequent bilateral 121 
skeletal muscle biopsies were obtained from the vastus lateralis at 1h and 3h after beverage 122 
ingestion to examine mTORC1-related signalling and associated localisation.  123 
Skeletal muscle immunohistochemistry. Skeletal muscle immunohistochemical preparation 124 
and staining was conducted as described previously (23). All samples from each subject were 125 
sectioned onto the same slide, in duplicate, to ensure accurate comparisons between time 126 
points could be made.  127 
Antibodies. The mouse mono-clonal anti-mTOR (#05-1592) antibody was purchased from 128 
Merck Chemical Ltd. (Nottingham, UK). The corresponding conjugated secondary antibody 129 
to this was Goat anti-mouse IgGγ1 Alexa®594 (#R37121, ThermoFisher, UK). Antibodies 130 
targeting LAMP2 (#AP1824d, Abgent, USA), Rictor (CST#53A2, Cell Signalling 131 
Technologies, USA) and Raptor (#ab40768, Abcam, Cambridge, UK) were visualised using 132 
Goat anti-rabbit IgG(H+L) Alexa®488 secondary antibodies (#A11008, ThermoFisher, UK). 133 
Finally, wheat germ agglutinin (WGA-350, #11263, ThermoFisher, UK) was used to identify 134 
the sarcolemmal membrane of muscle fibres. 135 
Antibody Validation. The specificity of Rictor (CST#53A2) and Raptor (Abcam#ab40768) 136 
primary antibodies were tested utilising skeletal muscle samples from the gastrocnemius of 137 
muscle-specific knockout (mKO) mice for each protein respectively (3). Wild-type, littermate 138 
muscle samples for each mouse model were used as controls. Primary antibodies were also 139 
omitted from a subset of samples on slides to examine any background staining from the 140 
secondary antibody utilised. The fluorescence intensity of each image was then calculated 141 
using ImageJ software (Version 1.51 for Windows). 142 
Image capture. Prepared slides were imaged as described previously (23). DAPI UV (340–143 
380 nm) filter was used to view WGA-350 (blue) signals and mTOR proteins tagged with 144 
Alexa Fluor 594 fluorophores (red) were visualised under the Texas red (540–580 nm) 145 
excitation filter. The FITC (465–495nm) excitation filter was used to capture signals of 146 
mTOR-complex proteins and LAMP2, which were conjugated with Alexa Fluor 488 147 
fluorophores. On average, 8 images were captured per section, and each image contained ~8 148 
muscle fibres such that around 120 fibres per time point (per subject) were used for analysis. 149 
Image processing and analysis was undertaken on ImagePro Plus 5.1 (Media Cybernetics, 150 
MD., USA.) and all factors i.e. exposure time and de-speckling, were kept constant between 151 
all images on each individual slide. Image signals generated by WGA were used to estimate 152 
cell membrane borders, which were merged with the corresponding target protein images to 153 
identify the association between the protein of interest and the plasma membrane. Pearson’s 154 
correlation coefficient (Image-Pro software) was used to quantify colocalization with the 155 
plasma membrane and mTOR-associated proteins. This process was also completed to 156 
quantify the localization of mTOR with complex-associated proteins (Raptor & Rictor) and a 157 
marker of the lysosomal membrane (LAMP2).  158 
AKT and S6K1 Kinase Activity Assays. At each time point during the experimental trial, a 159 
separate piece of muscle tissue was blotted and freed from any visible adipose or connective 160 
tissue. The tissue was then frozen in liquid nitrogen and stored at -80ºC. The kinase activity 161 
of AKT and S6K1 was determined via [-γ-32P] ATP kinase assays following immuno-162 
precipitation of the target protein, as previously described (18).  163 
Statistical Analysis. All statistical analysis was conducted on SPSS version 22 for Windows 164 
(SPSS Inc., Chicago, IL, USA). Differences in staining intensity between mKO, wild type 165 
(WT) and primary omitted (CON) muscle sections were analysed using a one-way analysis of 166 
variance (ANOVA). Differences in kinase activity, fluorescence intensity and staining 167 
colocalisation were analysed using a two-factor mixed-model ANOVA with two within 168 
subject factors (time; three levels – PRE.vs.1h.vs.3h and condition; two levels – 169 
FEDvs.EXFED), with Bonferonni correction for multiple comparisons. Pairwise comparisons 170 
were conducted when a significant main/interaction effect was found. Significance for all 171 
variables analysed was set at p≤.05. Data are presented as means±SEM unless otherwise 172 
stated. 173 
Results 174 
Rictor and Raptor antibodies are specific to their target proteins. Rictor protein staining 175 
intensity in Rictor mKO tissue was significantly lower than that in littermate WT controls 176 
(p<.001, Fig.1B). Furthermore, the staining intensity in this tissue was comparable to when 177 
the primary antibody was omitted in both mKO and WT tissue (p>.999, Fig.1B). Raptor 178 
protein staining intensity in Raptor mKO tissue was also significantly lower than that noted in 179 
littermate WT controls (p<.001, Fig.1C), with this staining intensity again similar to when the 180 
primary antibody was omitted in either tissue (p>.999, Fig.1C). Therefore, we take this as 181 
evidence that the Rictor (CST#53A2) and Raptor (Abcam#ab40768) antibodies are specific 182 
to their target protein.  183 
S6K1 and AKT kinase activity. A significant condition by time effect was observed for S6K1 184 
activity (p<.001). S6K1 activity rose above baseline in both conditions at 1h post-185 
exercise/feeding (FED-p=.015, EXFED-p<.001), and kinase activity at this time point was 186 
165% greater in the EXFED condition (p<.001, Fig.1D). At 3h post-exercise/feeding, kinase 187 
activity only remained above baseline values in the EXFED condition (52.8% greater than 188 
baseline, p=.037, Fig.1D). A significant main effect for time was noted for AKT kinase 189 
activity (p=.023, Fig.1E). Pairwise comparisons displayed a trend toward an increase in AKT 190 
kinase activity 1h post-intervention, when conditions were combined, compared to 3h post-191 
intervention (p=.073). 192 
Lysosomal content and colocalisation with mTOR. LAMP2 fluorescence intensity was 193 
unchanged from baseline in either condition, however a significantly greater intensity was 194 
noted in the EXFED condition, compared to FED, at 3h post-exercise/feeding (p=0.41, 195 
Fig.2B). A significant condition u time effect was observed for mTOR-Lamp2 colocalisation 196 
(p=.004). Consistent with our previous work (23), mTOR and LAMP2 were highly localised 197 
in basal skeletal muscle (Fig.2C). The colocalisation of these two proteins did not change 198 
from baseline in either condition over the 3h post-exercise/feeding period. However, at the 3h 199 
time point, the colocalisation of the proteins was greater in the FED condition compared to 200 
the EXFED condition (0.51(FED)vs.0.47(EXFED), p=.011, Fig. 2C).  201 
mTOR/lysosome translocation to the cell membrane. Significant main effects of condition 202 
(p=.05) and time (p=.025) were observed for mTOR colocalisation with the cell membrane 203 
(WGA positive staining). The significant main effect of condition suggests that, when all 204 
time points are combined, mTOR-WGA was greater in the EXFED condition compared to 205 
the FED condition. Subsequent pairwise comparisons also display that when both conditions 206 
were combined, mTOR colocalisation with the cell membrane was greater at 3h post-207 
exercise/feeding compared to baseline values (p=.008, Fig.2C). Further comparisons also 208 
displayed a trend toward a difference between mTOR-WGA colocalisation between 209 
conditions at the 3h time point (0.16(FED) vs. 0.19(EXFED), p=.085). This pattern of 210 
colocalisation was mirrored when analysing LAMP2-WGA colocalisation (main effect of 211 
time, p=.031, data not shown.), reiterating the constant colocalisation of mTOR and the 212 
lysosome.  213 
Rictor colocalisation with mTOR and WGA. Significant main effects of group (p=.046) and 214 
time (p=.035) were noted for Rictor colocalisation with mTOR proteins (Fig.3B). Overall, 215 
there was a greater colocalisation of these two proteins in the EXFED condition compared to 216 
the FED condition. Following pairwise comparisons, there was no difference in the 217 
colocalisation between Rictor and mTOR between any time points (p>.05, Fig.3B). 218 
Furthermore, Rictor colocalisation with WGA did not change from baseline at any time point 219 
in either condition (Fig.3C), suggesting post exercise translocation is specific to mTORC1.  220 
Raptor colocalisation with mTOR and WGA. The colocalisation of Raptor and mTOR 221 
proteins did not change in either group, at any time point, suggesting any alterations in sub-222 
cellular location of either protein occurred concurrently (Fig.4B). A significant condition x 223 
time effect was observed for Raptor colocalisation with WGA (p=.029). Here, Raptor 224 
colocalisation with WGA rose to a similar extent to the previously reported increase in 225 
mTOR-WGA colocalisation at 1h post-exercise/feeding in both conditions. At the 3h time 226 
point, Raptor-WGA colocalisation in the FED group dropped below baseline and 1h post-227 
ex/feeding levels (p=.007, Fig.4C), and colocalisation at this time point was greater in the 228 
EXFED condition (0.12(FED) vs. 0.17(EXFED), p=.014, Fig.4C). 229 
Discussion 230 
Utilising a within-subject design, we report that a combination of unilateral resistance 231 
exercise and protein-carbohydrate feeding elicits a greater mTOR translocation toward the 232 
cell membrane than feeding alone. This observation is consistent with previous findings from 233 
our laboratory in which we reported that mTOR associates with the lysosome in basal skeletal 234 
muscle, with mTOR/lysosomal complexes translocating to the cell periphery following 235 
mTOR activation (23). Utilising immunofluorescent approaches to distinguish between 236 
mTORC1 and mTORC2, the present study extends this observation, suggesting that 237 
mTORC1 seems to be the predominant mTOR complex translocating in human skeletal 238 
muscle following anabolic stimuli, with mTORC2 in constant association with the cell 239 
membrane.  240 
In addition to mTORC1 translocation to the cell periphery, we report a greater colocalisation 241 
of mTOR and LAMP2 in the FED condition, compared to the EXFED condition, at the 3h 242 
time point. This finding was unexpected and contrasted our previous research using a parallel 243 
group design (23). The greater association of mTORC1 with lysosomes in the FED condition 244 
would infer greater mTORC1 activity in this leg (13, 21); however, this was not apparent in 245 
our S6K1 kinase activity data. A possible explanation for this difference is the increased 246 
lysosomal content (LAMP2 fluorescence intensity) noted in the EXFED condition at this time 247 
point (Fig.2B). It is possible that the acute resistance exercise bout may have elicited an 248 
increase in chaperone assisted selective autophagy as a stress response to the strenuous 249 
exercise, as previously reported (24). This may have increased the free-lysosomal pool (24) 250 
and altered the ratio of mTOR-LAMP2 association. As this is only a proxy measure of 251 
lysosomal content, further research directed towards lysosomal biogenesis in response to 252 
physiological stimuli would be needed to address this mechanism.  253 
Previous research from our laboratory has shown an elevation in mTOR association with the 254 
cell membrane in response to resistance exercise, in both the fed and fasted state (23). This 255 
association coincided with an increase in S6K1 kinase activity, suggesting that mTOR 256 
trafficking is associated with an increase in intrinsic mTOR activity. Consistent with this 257 
hypothesis, here we report that mTORC1-cell membrane association increased 1h post-258 
intervention, in both FED and EXFED conditions, and the increment was similar to that noted 259 
in our previous work (23). However, in contrast to our previous results, mTOR-WGA 260 
colocalisation in the FED condition returned close to baseline values at 3h and colocalisation 261 
in the EXFED condition displayed a continued elevation. In addition to the main effects of 262 
time (p=.025) and condition (p=.05) apparent here, a trend toward greater colocalisation in 263 
the EXFED condition (p=.085) was noted at the 3h time point. This greater colocalisation is 264 
suggestive of retention of mTOR at the cell periphery when resistance exercise is followed 265 
with protein/carbohydrate ingestion, inferring a synergistic effect of resistance exercise and 266 
protein-carbohydrate feeding, an observation previously reported for MPS (5).  267 
The mTORC1 and mTORC2 protein complexes are involved in varying metabolic signalling 268 
processes in skeletal muscle, and as such are suggested to reside in distinct cellular locations 269 
(4). As mTOR-lysosome translocation has been previously associated with mTORC1 270 
activation in response to amino-acids in vitro (15), we sought to determine whether mTORC1 271 
is the principal mTOR complex translocating in human skeletal muscle as we have previously 272 
reported (23).The colocalisation of Raptor with WGA increased at 1h post-intervention in 273 
both conditions, and to a similar extent to that noted in mTOR-WGA colocalisation, 274 
suggesting that mTORC1 is a spatially regulated mTOR complex in human skeletal muscle. 275 
Further to this notion, a disparity between conditions became apparent at the 3h time point, 276 
with Raptor-WGA colocalisation enhanced in the EXFED condition (p=.014). This is in 277 
agreement with the data regarding mTOR-WGA colocalisation where a trend toward EXFED 278 
eliciting greater membrane colocalisation compared to FED is reported. Raptor colocalisation 279 
with mTOR itself was not altered at any time point, or between conditions, however we did 280 
observe a reduction in raptor association with WGA at 3h in both FED and EXFED.  We are 281 
currently unable to explain this result, however, it could be due to an increase in free Raptor 282 
content (14) or increased Raptor degradation (12), both potential mechanisms proposed to 283 
regulate mTORC1 activity. In contrast, co-staining of Rictor with WGA, suggested that 284 
mTORC2 localises with the cell membrane in basal tissue, with this colocalisation unaffected 285 
by resistance exercise or protein/carbohydrate ingestion. This finding has also been replicated 286 
using in vitro models, where a large proportion of mTORC2 activity was noted at the plasma 287 
membrane of HEK293 cells (10). 288 
Our data are congruent with both in vitro (15) and in vivo (23) studies suggesting that 289 
mTORC1 cellular colocalisation is linked to mTORC1 activity. Whilst this observation is in 290 
contrast to previous in vitro studies (21, 25), where mTOR translocation to the lysosome is 291 
deemed essential, we believe the increase in autophagy/MPB in post-absorptive skeletal 292 
muscle prevents the disassociation of mTOR and the lysosome noted in previous in vitro  293 
studies, where a complete amino acid withdrawal protocol is utilised. Further, many 294 
physiological mechanisms occur at the cell periphery suggesting the redistribution of 295 
mTORC1/lysosomal complexes to the cell periphery is physiologically relevant. mTORC1 is 296 
known to stimulate MPS which, through the use of the SUnSET technique (22) and 297 
immunohistochemical staining methods, is purported to occur primarily in peripheral regions 298 
of muscle fibres (11). Consistent with this, we previously identified mTOR to interact with 299 
Rheb, eIF3F and the microvasculature at the cell periphery following resistance exercise in 300 
the fed state (23). Collectively this data therefore suggests that both upstream regulators and 301 
downstream substrates of mTORC1 are membrane-associated in skeletal muscle (11). 302 
Further, given we observed that mTORC1 association with the cell periphery was prolonged 303 
with feeding [a scenario of heightened MPS], we propose that maintaining mTORC1 at the 304 
cell periphery may provide an mechanistic explanation as to why exercise in the fed state 305 
results in prolonged increases in MPS in human skeletal muscle compared to exercise or 306 
feeding in isolation (6).  307 
In summary, our data show that mTOR-lysosome translocation in response to resistance 308 
exercise and feeding is driven primarily by mTORC1, and occurs in parallel to increases in 309 
S6K1 activity. Further, we report that resistance exercise combined with protein-carbohydrate 310 
feeding sustains this response, compared to feeding alone, suggesting a synergistic effect of 311 
these two stimuli. Collectively, these data add further support to the importance of spatial 312 
regulation of mTORC1 in response to anabolic stimulation. Further research should now 313 
examine the relevance of mTORC1 colocalisation in clinical scenarios, i.e ageing (7) or 314 
obesity (2). Finally, the tools described herein to study mTORC2 localisation could be used 315 
to examine the regulation of skeletal muscle glucose uptake and insulin sensitivity, factors 316 
thought to be under the direct control of mTORC2 (16). 317 
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Figure headings 
Figure 1. Rictor and Raptor antibody validation and S6K1 and AKT kinase activity. 
Immuno-fluorescent staining of each protein was performed in mKO and littermate WT 
samples, in addition to staining of each sample with primary antibodies omitted (CON). 
Rictor/Raptor is displayed in green and WGA (cell membrane) is stained in blue. 
Representative images of staining in each condition are displayed (A) alongside the 
corresponding quantifications for Rictor (B) and Raptor (C). Scale bars are 50µm. Data 
presented as mean±SEM. *Significantly different WT (p<.001). S6K1 (D) and AKT (E) 
kinase activity following unilateral resistance exercise and/or protein-carbohydrate feeding. 
Black bars denote FED condition and open bars denote EXFED condition. Data presented as 
Mean±SEM. *Significantly different to baseline (p<.05), ¥significant difference between 
conditions at this time point (p<.001). 
Figure 2. The effect of resistance exercise and/or protein carbohydrate feeding on 
mTOR-LAMP2 and mTOR-WGA colocalisation. Representative images of mTOR-
LAMP2 and mTOR-WGA co-localisation at rest, and following resistance exercise and/or 
protein-carbohydrate feeding (A). Orange/yellow regions denote areas of mTOR localisation 
with the marker of the lysosome in images on the top row. mTOR-positive staining is shown 
in red, LAMP2-positive in green and WGA-positive in blue. Quantification of LAMP2 
fluorescence intensity (B), mTOR-LAMP2 colocalisation (C) and mTOR-WGA (D) co-
localisation at each time point. Scale bars are 50µm.  Data presented as Mean±SEM. 
¥Significant difference between conditions at this time point (p<.05), #significantly difference 
compared to baseline when conditions combined (p=.008). 
Figure 3. The effect of resistance exercise and/or protein carbohydrate feeding on 
Rictor-mTOR and Rictor-WGA colocalisation.  Representative images of Rictor-mTOR 
and Rictor-WGA co-localisation at rest, and following resistance exercise and/or protein-
carbohydrate feeding (A). Orange/yellow regions denote areas of Rictor localisation with 
mTOR on top row. mTOR-positive staining is shown in red, Rictor-positive in green and 
WGA-positive in blue Quantification of Rictor-mTOR (B) and Rictor-WGA (C) co-
localisation at each time point. Scale bars are 50µm. Data presented as Mean±SEM. 
Figure 4. The effect of resistance exercise and/or protein carbohydrate feeding on 
Raptor-mTOR and Raptor-WGA colocalisation. Representative images of Raptor-mTOR 
and Raptor-WGA co-localisation at rest, and following resistance exercise and/or protein-
carbohydrate feeding (A). Orange/yellow regions denote areas of Raptor localisation with 
mTOR. mTOR-positive staining is shown in red, Raptor-positive in green and WGA-positive 
in blue Quantification of Raptor-mTOR (B) and Raptor-WGA (C) co-localisation at each 
time point. Scale bar is 50µm. Data presented as Mean±SEM. ¥Significant difference between 
conditions at this time point (p=014), #significantly difference compared to baseline when 
conditions combined (p=.007). 




